Whan In Pharm Co.,Ltd.

KRX:016580.KS

12350 (KRW) • At close July 1, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

202420232022202120202019201820172016201520142013201220112010200920082007
Revenue 259,596.032230,393.579198,934.734177,775.701171,705.405159,176.972154,664.331147,953.429141,376.272145,397.202120,713.386104,479.91107,221.598110,052.051105,687.13999,386.53692,915.02180,091.447
Cost of Revenue 165,820.526132,268.078100,141.7484,283.35685,103.29379,996.29375,363.30969,107.99772,058.03272,817.63254,863.14446,842.02853,343.57653,879.89950,461.62447,295.20143,569.38334,311.712
Gross Profit 93,775.50598,125.50198,792.99593,492.34586,602.11279,180.67979,301.02278,845.43369,318.2472,579.5765,850.24257,637.88253,878.02156,172.15255,225.51552,091.33549,345.63845,779.735
Gross Profit Ratio 0.3610.4260.4970.5260.5040.4970.5130.5330.490.4990.5460.5520.5020.510.5230.5240.5310.572
Reseach & Development Expenses 771.131,072.4783,330.7652,659.1583,312.379993.271647.7671,167.063827.775619.7940000094.8911,807.4453,695.555
General & Administrative Expenses 18,194.23118,729.28717,590.68715,938.21814,923.21116,003.93312,261.67211,007.15312,618.20910,803.03210,033.5859,125.9258,493.368,011.6479,176.2429,334.9718,499.5146,263.597
Selling & Marketing Expenses 20,512.37717,688.88417,700.62113,140.73210,649.3847,561.82212,103.9913,424.45210,777.8228,750.6266,593.6086,477.2684,954.7746,016.0476,448.2068,347.1558,298.3136,358.699
SG&A 38,706.60865,345.09635,291.30829,078.9525,572.59523,565.75524,365.66224,431.60523,396.03119,553.65816,627.19315,603.19313,448.13414,027.69415,624.44817,682.12616,797.82712,622.296
Other Expenses 32,802.481030,360.50230,478.44229,298.82728,456.979-238.8125,969.206-156.87-167.448-1,341.026-532.569-681.132-507.763-701.101-873.845-1,358.456-757.021
Operating Expenses 72,280.21966,417.57468,982.57562,216.5558,183.80153,016.00551,958.31249,194.4447,693.16747,167.44341,844.94337,488.49435,587.37536,081.84134,889.60434,201.134,203.61431,101.849
Operating Income 21,495.28632,525.10329,810.4231,275.79528,418.31226,164.67427,342.7129,650.99321,625.07325,412.12824,005.29920,149.38818,290.64720,090.31120,335.91117,890.23515,142.02714,677.884
Operating Income Ratio 0.0830.1410.150.1760.1660.1640.1770.20.1530.1750.1990.1930.1710.1830.1920.180.1630.183
Total Other Income Expenses Net 5,451.791,268.209-2.256123.7652,663.482-71.125394.5226,820.722164.271,206.605191.6581,281.2681,975.841-1,154.2761,256.009626.368283.035944.638
Income Before Tax 26,947.07633,793.31229,808.16433,881.52831,081.79328,222.47629,322.84836,471.71521,789.34326,618.73324,196.95721,430.65620,266.48818,936.03521,591.9218,516.60315,425.06215,622.522
Income Before Tax Ratio 0.1040.1470.150.1910.1810.1770.190.2470.1540.1830.20.2050.1890.1720.2040.1860.1660.195
Income Tax Expense 3,566.3574,018.996,074.5777,423.0227,890.4969,610.4997,804.8899,299.4045,391.8886,109.0725,391.4216,850.5074,469.9254,323.9584,355.0124,082.0534,270.8254,346.897
Net Income 23,380.71929,774.32223,921.35126,659.623,387.7918,695.9521,517.95927,172.31116,397.45520,509.66118,805.53514,580.14915,796.56314,612.07717,236.90814,434.5511,154.23711,275.625
Net Income Ratio 0.090.1290.120.150.1360.1170.1390.1840.1160.1410.1560.140.1470.1330.1630.1450.120.141
EPS 1,532.371,9501,566.861,746.221,531.911,224.591,409.441,7801,0741,3431,2329551,0359681,183954735.5728.5
EPS Diluted 1,257.021,950.231,566.861,746.221,531.911,224.591,4091,7801,0741,3431,2329551,0359681,183954735.5728.5
EBITDA 33,442.6841,462.39834,671.80338,027.49132,488.14332,142.7831,982.01338,837.9823,810.5927,329.11625,895.57821,865.4619,762.16820,173.08322,774.01519,936.41218,499.10317,449.667
EBITDA Ratio 0.1290.180.1740.2140.1890.2020.2070.2630.1680.1880.2150.2090.1840.1830.2150.2010.1990.218